Key result
Each 1 mEq/L increase in time-averaged serum sodium level was associated with a 10% lower risk of new-onset cardiovascular events in peritoneal dialysis patients.
Why the study?
Does hyponatremia predict new-onset cardiovascular events in patients on peritoneal dialysis?
Observational (n=441)
Yes
Does hyponatremia predict new-onset cardiovascular events in patients on peritoneal dialysis?
In patients initiating peritoneal dialysis, time-averaged hyponatremia (≤ 138 mEq/L) is strongly associated with an increased risk of new-onset cardiovascular events.
Answers are grounded in this paper and cite their sources.
Hyponatremia may flag higher CV risk in PD patients; hypothesis-generating and requires prospective trials before informing care.
BACKGROUND AND AIM: Cardiovascular (CV) disease is the leading cause of morbidity and mortality in patients on peritoneal dialysis (PD). Hyponatremia was recently shown to be a modifiable factor that is strongly associated with increased mortality in PD patients. However, the clinical impact of hyponatremia on CV outcomes in these patients is unclear. METHODS: To determine whether a low serum sodium level predicts the development of CV disease, we carried out a prospective observational study of 441 incident patients who started PD between January 2000 and December 2005. Time-averaged serum sodium (TA-Na) levels were determined to investigate the ability of hyponatremia to predict newly developed CV events in these patients. RESULTS: During a mean follow-up of 43.2 months, 106 (24.0%) patients developed new CV events. The cumulative incidence of new-onset CV events after the initiation of PD was significantly higher in patients with TA-Na levels ≤ 138 mEq/L than in those with a TA-Na > 138 mEq/L. After adjustment for multiple potentially confounding covariates, an increase in TA-Na level was found to be associated with a significantly lower risk of CV events (subdistribution hazard ratio per 1 mEq/L increase, 0.90; 95% confidence interval, 0.83-0.96; p = 0.003). Patients with a TA-Na ≤ 138 mEq/L had a 2.31-fold higher risk of suffering a CV event. CONCLUSIONS: These results provide evidence of a clear association between low serum sodium and new-onset CV events after dialysis initiation in PD patients. Whether the correction of hyponatremia for this indication provides additional protection for the development of CV disease in these patients remains to be addressed in interventional studies.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2015) conducted an observational in Peritoneal Dialysis (n=441). Time-averaged serum sodium (TA-Na) level vs. Higher TA-Na level (per 1 mEq/L increase) was evaluated on First occurrence of a fatal or nonfatal cardiovascular event (SHR 0.90, 95% CI 0.83-0.96, p=0.003). Each 1 mEq/L increase in time-averaged serum sodium level was associated with a 10% lower risk of new-onset cardiovascular events in peritoneal dialysis patients.
Synapse has enriched 10 related papers. Consider them for comparative context: